BrownE.A., DaviesS.J., RutherfordP., MeeusF., BorrasM., RiegelW.Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study.J Am Soc Nephrol2003; 14: 2948–57.
2.
SitterT., SauterM.Impact of glucose in peritoneal dialysis: saint or sinner?Perit Dial Int2005; 25: 415–25.
3.
Rodriguez-CarmonaA., Perez FontanM., Garcia LopezE., Garcia FalconT., Diaz CambreH.Use of icodextrin during nocturnal automated peritoneal dialysis allows sustained ultrafiltration while reducing the peritoneal glucose load: a randomized crossover study.Perit Dial Int2007; 27: 260–6.
4.
FreidaP., GalachM., Divino FilhoJ.C., WerynskiA., LindholmB.Combination of crystalloid (glucose) and colloid (icodextrin) osmotic agents markedly enhances peritoneal fluid and solute transport during the long PD dwell.Perit Dial Int2007; 27: 267–76.
5.
MedcalfJ.F., HarrisK.P., WallsJ.Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis.Kidney Int2001; 59: 1128–33.
6.
DaviesS.J., PhillipsL., NaishP.F., RussellG.I.Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis.J Am Soc Nephrol2001; 12: 1046–51.
7.
Le PooleC.Y., WeltenA.G., WeijmerM.C., ValentijnR.M., van IttersumF.J., ter WeeP.M.Initiating CAPD with a regimen low in glucose and glucose degradation products, with icodextrin and amino acids (NEPP) is safe and efficacious.Perit Dial Int2005; 25(Suppl 3): S64–8.
8.
PeersE.Icodextrin plus glucose combinations for use in CAPD.Perit Dial Int1997; 17(Suppl 2): S68–9.
9.
RippeB., LevinL.Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD.Kidney Int2000; 57: 2546–56.
10.
JenkinsS.B., WilkieM.E.An exploratory study of a novel peritoneal combination dialysate (1.36% glucose/7.5% icodextrin), demonstrating improved ultrafiltration compared to either component studied alone.Perit Dial Int2003; 23: 475–80.
11.
DallasF., JenkinsS.B., WilkieM.E.Enhanced ultrafiltration using 7.5% icodextrin/1.36% glucose combination dialysate: a pilot study.Perit Dial Int2004; 24: 542–6.
Van BiesenW., BoerW., De GreveB., DequidtC., VijtD., FaictD.A randomized clinical trial with a 0.6% amino acid/1.4% glycerol peritoneal dialysis solution.Perit Dial Int2004; 24: 222–30.
14.
TjiongH.L., van den BergJ.W., WattimenaJ.L., RietveldT., van DijkL.J., van der WielA.M.Dialysate as food: combined amino acid and glucose dialysate improves protein anabolism in renal failure patients on automated peritoneal dialysis.J Am Soc Nephrol2005; 16: 1486–93.
15.
FallerB., AparicioM., FaictD., De VosC., de PrecigoutV., LarroumetN.Clinical evaluation of an optimized 1.1% amino-acid solution for peritoneal dialysis.Nephrol Dial Transplant1995; 10: 1432–7.
16.
ParkM.S., HeimburgerO., BergstromJ., WaniewskiJ., WerynskiA., LindholmB.Peritoneal transport during dialysis with amino acid-based solutions.Perit Dial Int1993; 13: 280–8.
17.
KoningsC.J., KoomanJ.P., SchonckM., GladziwaU., WirtzJ., van den Wall BakeA.W.Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study.Kidney Int2003; 63: 1556–63.
18.
DaviesS.J., WoodrowG., DonovanK., PlumJ., WilliamsP., JohanssonA.C.Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial.J Am Soc Nephrol2003; 14: 2338–44.
19.
VychytilA., HorlW.H.The role of tidal peritoneal dialysis in modern practice: a European perspective.Kidney Int Suppl2006; 103: S96–103.
20.
Garcia-LopezE., AnderstamB., HeimburgerO., AmiciG., WerynskiA., LindholmB.Determination of high and low molecular weight molecules of icodextrin in plasma and dialysate, using gel filtration chromatography, in peritoneal dialysis patients.Perit Dial Int2005; 25: 181–91.
21.
PosthumaN., ter WeeP.M., DonkerA.J., OeP.L., van DorpW., PeersE.M.Serum disaccharides and osmolality in CCPD patients using icodextrin or glucose as daytime dwell.Perit Dial Int1997; 17: 602–7.
22.
PosthumaN., ter WeeP.M., VerbrughH.A., OeP.L., PeersE., SayersJ.Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-h dialysate creatinine clearance.Nephrol Dial Transplant1997; 12: 550–3.
23.
GokalR., MoberlyJ., LindholmB., MujaisS.Metabolic and laboratory effects of icodextrin.Kidney Int Suppl2002; 81: S62–71.
24.
GraddenC.W., AhmadR., BellG.M.Peritoneal dialysis: new developments and new problems.Diabet Med2001; 18: 360–3.
25.
KredietR.T.Dry body weight: water and sodium removal targets in PD.Contrib Nephrol2006; 150: 104–10.
26.
GraffJ., FuglebergS., BrahmJ., Fogh-AndersenN.Trans-peritoneal transport of sodium during hypertonic peritoneal dialysis.Clin Physiol1996; 16: 31–9.
27.
AtesK., NergizogluG., KevenK., SenA., KutlayS., ErturkS.Effect of fluid and sodium removal on mortality in peritoneal dialysis patients.Kidney Int2001; 60: 767–76.
28.
SmitW., ParikovaA., StruijkD.G., KredietR.T.The difference in causes of early and late ultrafiltration failure in peritoneal dialysis.Perit Dial Int2005; 25(Suppl 3): S41–5.
